Clinical trial
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex…
NCT00006132 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00006132 |
|---|---|
| Title | Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | University of Alabama at Birmingham |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Simplex |
| Intervention type | Drug |
| Interventions | acyclovir |
| Enrollment | 132 |
| Start date | Jun 1, 1997 |
| First posted | Aug 4, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: